Oral Candidiasis: Clinical Forms, Diagnosis, and Antifungal Management

Oral candidiasis is the most common fungal infection of the mouth, caused by overgrowth of Candida species, most often Candida albicans. It ranges from a harmless white coating to painful, chronic conditions that signal an underlying immune or local problem.

Why Candida Overgrows

Candida is a normal commensal organism found in the oral cavity of many healthy individuals. Disease develops when the balance of the oral environment is disturbed. Predisposing factors include the use of broad-spectrum antibiotics, inhaled corticosteroids, xerostomia, denture wearing, smoking, and systemic conditions such as diabetes and immunosuppression.

Because Candida thrives in an acidic, moist environment, poor oral hygiene and high sugar intake also promote overgrowth. Understanding the predisposing factor is essential, since treating the infection without addressing its cause leads to recurrence.

Clinical Forms

Pseudomembranous candidiasis, or thrush, is the most recognizable form, appearing as soft white plaques that can be wiped away, leaving a raw, bleeding surface. Erythematous candidiasis is often associated with inhaled steroid use or HIV infection and may be mistaken for a vitamin deficiency.

Diagnosis

Diagnosis is usually clinical, based on the appearance and distribution of the lesions and the presence of predisposing factors. When the diagnosis is uncertain, a smear can be taken and examined for fungal hyphae and yeast cells, or a swab can be sent for culture.

In persistent or atypical cases, biopsy may be required to exclude other conditions, particularly hyperplastic candidiasis, which can resemble leukoplakia and carries a small risk of dysplasia. A therapeutic trial of an antifungal agent can also help confirm the diagnosis.

Antifungal Management

Topical antifungals are the first line of treatment for most forms of oral candidiasis. Nystatin suspension or pastilles, clotrimazole troches, and miconazole gel are commonly used. Treatment should continue for several days after symptoms resolve to prevent recurrence.

For severe, refractory, or immunocompromised patients, systemic antifungals such as fluconazole are indicated. Drug interactions must be considered, particularly with medications metabolized by the liver, and resistance is an increasing concern in patients with repeated or prolonged exposure.

Addressing Predisposing Factors

Successful management requires eliminating or controlling the underlying cause. This may include adjusting antibiotic therapy, reviewing inhaled steroid use and rinsing the mouth after inhalation, improving glycemic control in diabetes, and managing xerostomia.

For denture-related candidiasis, the denture must be disinfected and ideally removed at night, and the fitting surface should be kept clean. Patients should be advised to replace worn dentures and to maintain meticulous oral and denture hygiene.

Prevention and Follow-Up

Prevention focuses on maintaining a healthy oral environment: good oral hygiene, a balanced diet low in refined sugar, adequate saliva flow, and regular dental care. Patients using inhaled corticosteroids should rinse with water after each use.

Recurrent or persistent candidiasis warrants investigation for underlying systemic disease, including diabetes and immune deficiency. With appropriate treatment and correction of predisposing factors, most cases of oral candidiasis resolve completely and remain controlled.

Candidiasis in Special Populations

In immunocompromised patients, including those with HIV infection, chemotherapy, or organ transplantation, oral candidiasis can be severe, recurrent, and difficult to treat. Esophageal involvement may accompany oral disease, and systemic antifungal therapy is often required. These patients should be managed in close collaboration with their medical team.

In infants, oral thrush is common and usually responds well to topical nystatin. Breastfeeding mothers may require simultaneous treatment to prevent reinfection. In elderly patients, candidiasis is frequently associated with dentures, reduced saliva, and polypharmacy, and a comprehensive approach is needed.

Antifungal Resistance

Repeated or prolonged use of antifungal agents, particularly fluconazole, can select for resistant strains of Candida. Resistance is a growing concern in patients with chronic or recurrent candidiasis, especially those who are immunocompromised. Suspected resistance should prompt culture and susceptibility testing.

When resistance is identified, alternative agents such as itraconazole, posaconazole, or topical amphotericin B may be used. Prevention of resistance relies on correct dosing, completing the full course of treatment, and addressing the underlying predisposing factors rather than relying on repeated courses of medication.

Patient Education and Prevention

Patients should be educated about the importance of oral hygiene, denture care, and a diet low in refined sugar. Those using inhaled corticosteroids should rinse and gargle with water after each use to reduce the risk of oral candidiasis. Regular dental visits allow early detection and treatment.

For patients with xerostomia, saliva substitutes and stimulation can help maintain a healthy oral environment that resists Candida overgrowth. With a combination of appropriate antifungal therapy and correction of predisposing factors, oral candidiasis can be effectively controlled and recurrence minimized.